Direct answer

FDA clearance means the agency determined through the 510(k) process that a device is substantially equivalent to a legally marketed predicate for its stated intended use. FDA clearance is not FDA approval, does not mean devices are identical, and does not prove superiority or decades of clinical performance. A cleared implant still requires system-specific evidence and individualized clinical judgment.

Key takeaways

  • Most endosseous dental implants are Class II devices reviewed through the 510(k) pathway
  • FDA clearance and FDA approval are not interchangeable terms
  • Substantial equivalence does not mean two devices are identical
  • A clearance summary can identify intended use, design, materials, predicates, and submitted test categories
  • Clearance does not replace clinical evidence, treatment planning, or a patient-specific recommendation

What is the 510(k) pathway?

A 510(k) is a premarket notification submitted to the U.S. Food and Drug Administration for a device that is not exempt and does not require a premarket approval application. Endosseous root-form dental implants are generally Class II devices. Before marketing, the submitter must receive an FDA order finding the device substantially equivalent to a legally marketed device.2

The accurate description after a successful determination is cleared for marketing or FDA-cleared through the 510(k) process. “Approved” describes a different regulatory pathway and should not be substituted for “cleared.”4

What does substantial equivalence mean?

FDA states that the new device must have the same intended use as its predicate. It may have the same technological characteristics, or it may have different technological characteristics that do not raise different questions of safety and effectiveness, with submitted information demonstrating that the device is as safe and effective as the legally marketed predicate.2

Substantially equivalent does not mean identical. A subject device may differ in design, material details, dimensions, surface, components, or other technology. The clearance record should be read to identify those differences and the information used in the regulatory comparison.

What can a clearance record tell a patient?

A 510(k) record can identify the device class and product code, prescription status, cleared indications for use, material, one-piece or two-piece architecture, dimensions and components, surface treatment, sterilization method, predicates or reference devices, and the categories of performance information submitted when those details appear in the summary. FDA also advises patients to ask for the brand and model of their dental implant system and retain that information.1

Read the record for the exact model and component under consideration. Clearance of one implant body, abutment, size, or system configuration should not be assumed to cover every product, component combination, or use offered by a manufacturer.

What does clearance not establish?

Clearance does not establish that a device is superior to its predicate or to another implant material. It is not an FDA endorsement, a finding that different systems are interchangeable, a guarantee of longevity, or proof for every possible indication. A record also cannot establish that an implant is suitable for an individual patient.

Human clinical evidence, system-specific follow-up, the treating team’s experience, diagnosis, anatomy, restorative design, risk factors, and maintenance planning remain necessary. Regulatory authorization and a patient-specific treatment recommendation answer different questions.

How the CeraRoot records illustrate system change

K093595 describes the CeraRoot Implant System as a one-piece zirconia implant and abutment with an acid-etched surface. Its cleared indications state that it is not intended for immediate loading.5

K242072 describes CeraRoot TL as a two-piece, tissue-level Y-TZP zirconia variant. Its separately manufactured abutment is made from the same material as the implant and is cemented into the implant; the stated protocol uses delayed loading.6

The later record uses the original system as its primary predicate and also lists reference devices. Those relationships document the regulatory comparison. They do not make the one-piece and two-piece systems, their components, or other referenced products clinically interchangeable.

Questions to ask about a cleared implant

  • What is the exact implant model and 510(k) clearance number?
  • What intended use and loading protocol does the clearance cover?
  • What material, surface, architecture, dimensions, and components are described in the record?
  • How does this device differ from its predicate or listed reference devices?
  • What human clinical evidence supports this exact system and my indication?
  • What experience does the surgical and restorative team have with this system?
  • How will maintenance, component complications, repair, or replacement be managed?

Selected references

  1. U.S. Food and Drug Administration. Dental Implants: What You Should Know. FDA patient information.
  2. U.S. Food and Drug Administration. Premarket Notification 510(k). FDA 510(k) guidance.
  3. U.S. Food and Drug Administration. The 510(k) Program: Evaluating Substantial Equivalence in Premarket Notifications. FDA substantial-equivalence guidance.
  4. U.S. Food and Drug Administration. Device Approvals and Clearances. FDA pathway overview.
  5. U.S. Food and Drug Administration. 510(k) Summary K093595: CeraRoot Implant System. FDA record K093595.
  6. U.S. Food and Drug Administration. 510(k) Summary K242072: CeraRoot TL Implant System. FDA record K242072.